Morán-Jiménez et al., 2020 - Google Patents
Molecular analysis of 55 Spanish patients with acute intermittent porphyriaMorán-Jiménez et al., 2020
View HTML- Document ID
- 4721863546789860847
- Author
- Morán-Jiménez M
- Borrero-Corte M
- Jara-Rubio F
- García-Pastor I
- Díaz-Díaz S
- Castelbón-Fernandez F
- Enríquez-de-Salamanca R
- Méndez M
- Publication year
- Publication venue
- Genes
External Links
Snippet
Acute intermittent porphyria (AIP) results from a decreased activity of hepatic hydroxymethylbilane synthase (HMBS), the third enzyme in the heme biosynthetic pathway. AIP is an autosomal dominant disorder with incomplete penetrance, characterized by acute …
- 208000005452 Acute Intermittent Porphyria 0 title abstract description 55
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/28—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for programming tools or database systems, e.g. ontologies, heterogeneous data integration, data warehousing or computing architectures
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
- C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wang et al. | Application of whole exome and targeted panel sequencing in the clinical molecular diagnosis of 319 Chinese families with inherited retinal dystrophy and comparison study | |
Gonçalves et al. | Exonization of an intronic LINE-1 element causing becker muscular dystrophy as a novel mutational mechanism in dystrophin gene | |
Tracewska-Siemiątkowska et al. | An expanded multi-organ disease phenotype associated with mutations in YARS | |
Dabaj et al. | NGLY1 deficiency: a rare newly described condition with a typical presentation | |
Kistol et al. | Leigh syndrome: spectrum of molecular defects and clinical features in Russia | |
Valero et al. | Aberrant splicing events associated to CDH23 noncanonical splice site mutations in a proband with atypical Usher syndrome 1 | |
Morán-Jiménez et al. | Molecular analysis of 55 Spanish patients with acute intermittent porphyria | |
Bychkov et al. | Complex transposon insertion as a novel cause of pompe disease | |
Bestetti et al. | Expanding the molecular spectrum of ANKRD11 gene defects in 33 patients with a clinical presentation of KBG syndrome | |
Cheng et al. | Candidate modifier genes for the penetrance of Leber’s hereditary optic neuropathy | |
Nasca et al. | Biallelic variants in ENDOG associated with mitochondrial myopathy and multiple mtDNA deletions | |
Capra et al. | Coexistence of genetic diseases is a new clinical challenge: three unrelated cases of dual diagnosis | |
Musumeci et al. | Identification of a novel missense mutation of POLR3A gene in a cohort of sicilian patients with leukodystrophy | |
Ye et al. | Single nucleotide polymorphisms of ALDH18A1 and MAT2A genes and their genetic associations with milk production traits of Chinese Holstein cows | |
Yao et al. | Effects of SNPs in AANAT and ASMT genes on milk and peripheral blood melatonin concentrations in Holstein cows (Bos taurus) | |
Tripathi et al. | Impact of genetic polymorphisms in modifier genes in determining fetal hemoglobin levels in beta-thalassemia | |
Serrano-Lorenzo et al. | Clinical, biochemical, and molecular characterization of two families with novel mutations in the LDHA gene (GSD XI) | |
Maksemous et al. | Comprehensive exonic sequencing of known ataxia genes in episodic ataxia | |
Harteveld et al. | Loss-of-function variants in SUPT5H as modifying factors in Beta-Thalassemia | |
La Cognata et al. | A comprehensive, targeted NGS approach to assessing molecular diagnosis of lysosomal storage diseases | |
Alesi et al. | Deep intronic LINE-1 insertions in NF1: expanding the spectrum of neurofibromatosis type 1-associated rearrangements | |
Rudd Garces et al. | FYCO1 Frameshift deletion in wirehaired pointing griffon dogs with juvenile cataract | |
Di Rado et al. | Detection of germline mutations in a cohort of 250 relatives of mutation carriers in multigene panel: impact of pathogenic variants in other genes beyond BRCA1/2 | |
Riskin et al. | The Genetics of Glucose-6-phosphate-dehydrogenase (G6PD) and Uridine Diphosphate Glucuronosyl Transferase 1A1 (UGT1A1) promoter gene polymorphism in relation to quantitative biochemical G6PD activity measurement and neonatal hyperbilirubinemia | |
Almatrafi et al. | Homozygous duplication in the CHRNE in a family with congenital myasthenic syndrome 4C: 18-year follow up |